High rates of associated morbidity and mortality justify flu vaccination

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Ortiz, Justin R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LETTER; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; INFLUENZA, HUMAN; MASS IMMUNIZATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS VACCINATION;

EID: 84915748280     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7450     Document Type: Letter

References (5)

1. McCartney M. What use is mass flu vaccination? BMJ 2014;349:g6182. (20 October.)
2. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:36-44.
3. Thompson MG, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, et al. Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillance network sites. Clin Infect Dis 2013;57:1587-92.
4. McNeil S, Shinde V, Andrew M, Hatchette T, Leblanc J, Ambrose A, et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveill 2014;19:20729.
5. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371:635-45.